Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003908
Filing Date
2021-11-10
Accepted
2021-11-10 07:16:12
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrr-20210930.htm   iXBRL 10-Q 2894973
2 EX-31.1 tcrr-ex31_1.htm EX-31.1 18594
3 EX-31.2 tcrr-ex31_2.htm EX-31.2 18686
4 EX-32.1 tcrr-ex32_1.htm EX-32.1 15283
5 GRAPHIC img15122369_0.jpg GRAPHIC 167882
  Complete submission text file 0000950170-21-003908.txt   9296163

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrr-20210930.xsd EX-101.SCH 47970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrr-20210930_pre.xml EX-101.PRE 308259
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrr-20210930_lab.xml EX-101.LAB 427754
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrr-20210930_def.xml EX-101.DEF 166219
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrr-20210930_cal.xml EX-101.CAL 52469
11 EXTRACTED XBRL INSTANCE DOCUMENT tcrr-20210930_htm.xml XML 1599343
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

EIN.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38811 | Film No.: 211394386
SIC: 2836 Biological Products, (No Diagnostic Substances)